Project
AMGEN202100057
Completed · 2022 until 2023
Rickli Hans, Vetsch Susanne, Bilz Stefan, Räss Andrea
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2022
End Date
2023
Financing
Industry
Study Design
Multicenter, cross-sectional to summarize the Lp(a) distribution in subjects with history of MI and/or PCI. Subjects are eligible if their Lp(a) value is known to be >= 90mg/dl, or is unknown. In that case Lp(a) will be determined.
Partner
Kardiologie und Endokrinologie, KSSG
Brief description/objective
A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD).
The purpose of the study is to characterize the distribution of Lp(a) levels among subjects with ASCVD.